Israel’s Redhill has completed its Phase 2 / 3 clinical trials of its opaganib treatment on 475 coronavirus patients in Israel, Europe and Brazil. In a few weeks it will declare the results. Opaganib works on the patient rather than the virus, preventing the body from allowing the virus to enter the host cells.
https://worldisraelnews.com/israeli-research-a-simple-pill-to-treat-covid-19/